<HashMap><database>ecrin-mdr-crc</database><scores/><additional><omics_type>Clinical</omics_type><study_start_year>2013</study_start_year><condition>Opioid-induced Constipation in Subjects with Non-malignant Chronic Pain Receiving Opioid Therapy</condition><condition>Opioid-Induced Constipation</condition><condition>Opioid induced constipation</condition><condition>Constipation</condition><disease>Opioid Induced Constipation</disease><disease>Opioid-induced Constipation</disease><disease>Constipation</disease><disease>Opioid-induced Constipation In Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy</disease><study_type>Interventional</study_type><full_dataset_link>https://newmdr.ecrin.org/Study/2153377</full_dataset_link><location>Hungary</location><location>Czechia</location><location>United States</location><location>United Kingdom</location><location>Portugal</location><location>Spain</location><location>Canada</location><location>Sweden</location><location>Austria</location><location>Belgium</location><location>Denmark</location><location>Poland</location><location>Italy</location><location>South Africa</location><location>Israel</location><location>France</location><location>Australia</location><location>Germany</location><location>Estonia</location><study_start_month>9</study_start_month><keyword>Naldemedine</keyword><keyword>Opioid Induced Constipation</keyword><repository>ECRIN MDR</repository><study_status>Completed</study_status></additional><is_claimable>false</is_claimable><name>Long Term Safety of Naldemedine</name><description>The purpose of this study is to evaluate the long-term safety of naldemedine for the treatment of constipation due to opioid therapy.</description><dates><creation>2013-09-15</creation></dates><accession>2153377</accession><cross_references><ClinicalTrials___gov>NCT01965652</ClinicalTrials___gov><EU Clinical Trials Register>2013-002949-11</EU Clinical Trials Register></cross_references></HashMap>